XML 58 R41.htm IDEA: XBRL DOCUMENT v3.19.2
CHANGES IN ACCOUNTING POLICIES (Tables)
12 Months Ended
Mar. 31, 2019
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Disclosure of expected impact of initial application of new standards
The cumulative effect of the impacts of adopting IFRS 15 are presented in the tables below:

Reconciliation of financial position
 
April 1, 2017
 
 
March 31, 2018
 
As previously
 
 
IFRS 15

 
As previously
 
 
IFRS 15

 
(amounts in millions)
reported
 
Adjustments
 
As restated
 
reported
 
Adjustments
 
As restated
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
504.7

 
$

 
$
504.7

 
$
611.5

 
$

 
$
611.5

Accounts receivable
 
548.4

 
(98.3
)
 
450.1

 
568.4

 
(116.4
)
 
452.0

Contracts in progress: assets
 
337.5

 
(337.5
)
 

 
401.6

 
(401.6
)
 

Contract assets
 

 
348.5

 
348.5

 

 
439.7

 
439.7

Inventories
 
416.3

 
132.7

 
549.0

 
375.3

 
140.8

 
516.1

Prepayments
 
63.8

 

 
63.8

 
50.0

 

 
50.0

Income taxes recoverable
 
25.6

 

 
25.6

 
40.7

 

 
40.7

Derivative financial assets
 
23.4

 

 
23.4

 
13.3

 

 
13.3

Total current assets
 
$
1,919.7


$
45.4


$
1,965.1


$
2,060.8


$
62.5


$
2,123.3

Property, plant and equipment
 
1,582.6

 

 
1,582.6

 
1,803.9

 

 
1,803.9

Intangible assets
 
944.0

 

 
944.0

 
1,055.6

 

 
1,055.6

Investment in equity
 
 
 
 
 

 
 
 
 
 

accounted investees
 
378.4

 
(2.6
)
 
375.8

 
244.5

 
(1.8
)
 
242.7

Deferred tax assets
 
42.8

 
0.1

 
42.9

 
60.9

 
0.3

 
61.2

Derivative financial assets
 
16.0

 

 
16.0

 
11.5

 

 
11.5

Other assets
 
471.3

 

 
471.3

 
482.0

 

 
482.0

Total assets
 
$
5,354.8

 
$
42.9

 
$
5,397.7

 
$
5,719.2

 
$
61.0

 
$
5,780.2

 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities and equity
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and
 
 
 
 
 
 
 
 
 
 
 
 
accrued liabilities
 
$
695.2

 
$
(9.1
)
 
$
686.1

 
$
669.6

 
$
(2.7
)
 
$
666.9

Provisions
 
43.2

 

 
43.2

 
32.1

 

 
32.1

Income taxes payable
 
9.6

 

 
9.6

 
15.3

 

 
15.3

Deferred revenue
 
266.6

 
(255.2
)
 
11.4

 
371.5

 
(361.5
)
 
10.0

Contracts in progress:
 
 
 
 
 

 
 
 
 
 

liabilities
 
191.9

 
(191.9
)
 

 
161.8

 
(161.8
)
 

Contract liabilities
 

 
593.4

 
593.4

 

 
679.5

 
679.5

Current portion of
 
 
 
 
 

 
 
 
 
 

long-term debt
 
51.9

 

 
51.9

 
52.2

 

 
52.2

Derivative financial liabilities
 
15.5

 

 
15.5

 
18.1

 

 
18.1

Total current liabilities
 
$
1,273.9

 
$
137.2

 
$
1,411.1

 
$
1,320.6

 
$
153.5

 
$
1,474.1

Provisions
 
39.1

 

 
39.1

 
39.5

 

 
39.5

Long-term debt
 
1,203.5

 

 
1,203.5

 
1,208.7

 

 
1,208.7

Royalty obligations
 
138.5

 

 
138.5

 
140.8

 

 
140.8

Employee benefits obligations
 
157.7

 

 
157.7

 
200.6

 

 
200.6

Deferred gains
 
 
 
 
 

 
 
 
 
 

and other liabilities
 
217.8

 

 
217.8

 
229.9

 

 
229.9

Deferred tax liabilities
 
238.6

 
(25.6
)
 
213.0

 
208.1

 
(23.4
)
 
184.7

Derivative financial liabilities
 
4.7

 

 
4.7

 
4.4

 

 
4.4

Total liabilities
 
$
3,273.8

 
$
111.6

 
$
3,385.4

 
$
3,352.6

 
$
130.1

 
$
3,482.7

Equity
 
 
 
 
 
 
 
 
 
 
 
 
Share capital
 
$
615.4

 
$

 
$
615.4

 
$
633.2

 
$

 
$
633.2

Contributed surplus
 
19.4

 

 
19.4

 
21.3

 

 
21.3

Accumulated other
 
 
 
 
 

 
 
 
 
 

comprehensive income
 
193.7

 
(2.6
)
 
191.1

 
262.3

 
(2.0
)
 
260.3

Retained earnings
 
1,192.3

 
(66.1
)
 
1,126.2

 
1,381.4

 
(67.1
)
 
1,314.3

Equity attributable to equity
 
 
 
 
 
 
 
 
 
 
 
 
holders of the Company

 
$
2,020.8

 
$
(68.7
)
 
$
1,952.1

 
$
2,298.2

 
$
(69.1
)
 
$
2,229.1

Non-controlling interests
 
60.2

 

 
60.2

 
68.4

 

 
68.4

Total equity
 
$
2,081.0

 
$
(68.7
)
 
$
2,012.3

 
$
2,366.6

 
$
(69.1
)
 
$
2,297.5

Total liabilities and equity
 
$
5,354.8

 
$
42.9

 
$
5,397.7

 
$
5,719.2

 
$
61.0

 
$
5,780.2



Reconciliation of net income
 
 
 
Year ended March 31, 2018
 
 
 
As previously
 
 
IFRS 15

 
 
reported
reported
 
Adjustments
 
As restated
 
Revenue
 
 
$
2,830.0

 
$
(6.5
)
 
$
2,823.5

Cost of sales
 
 
1,953.1

 
(7.5
)
 
1,945.6

Gross profit
 
 
$
876.9

 
$
1.0

 
$
877.9

Research and development
 
 
 
 
 
 
 
expenses
 
 
114.9

 

 
114.9

Selling, general and
 
 
 
 
 
 
 
administrative expenses
 
 
380.8

 

 
380.8

Other gains – net
 
 
(37.4
)
 

 
(37.4
)
After tax share in profit of equity
 
 
 
 
 
 
 
accounted investees
 
 
(42.4
)
 
(0.8
)
 
(43.2
)
Operating profit
 
 
$
461.0

 
$
1.8

 
$
462.8

Finance expense – net
 
 
76.2

 
1.0

 
77.2

Earnings before income taxes
 
 
$
384.8

 
$
0.8

 
$
385.6

Income tax expense
 
 
29.1

 
1.8

 
30.9

Net income
 
 
$
355.7

 
$
(1.0
)
 
$
354.7

Attributable to:
 
 
 
 
 
 
 
Equity holders of the Company
 
 
$
347.0

 
$
(1.0
)
 
$
346.0

Non-controlling interests
 
 
8.7

 

 
8.7

Earnings per share attributable to
 
 
 
 
equity holders of the Company
 
 
 
 
 
 
 
Basic
 
 
$
1.29

 
$

 
$
1.29

Diluted
 
 
$
1.29

 
$
(0.01
)
 
$
1.28